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Abstract 1 
Introduction: There is a need to develop simple, non-invasive and sensitive outcome measures 2 
for respiratory therapy. Adventitious respiratory sounds (i.e., crackles and wheezes) can be 3 
objectively characterized with computerized respiratory sound analysis and have been shown to 4 
contribute for diagnosis purposes however; their potential to be used as outcome measures is 5 
unknown. Thus, this systematic review synthetizes the evidence on the use of computerized 6 
adventitious respiratory sounds as outcome measures. 7 
Methods: The Web of knowledge, MEDLINE, EMBASE and SCOPUS databases were 8 
searched. Reviewers independently selected studies according to the eligibility criteria. Effect 9 
sizes and 95% confidence intervals were computed. 10 
Results: Twelve studies with different designs (observational (n=3), quasi-experimental (n=7) 11 
and randomized controlled trial (n=2)) were included. Eight studies were conducted with adults 12 
and four with children. Most studies explored only one type of adventitious respiratory sound. 13 
For wheezes, the occupation rate seemed to be the most promising parameter to be used as an 14 
outcome measure, with high/medium effect sizes (from 0.62 to 1.82). For crackles, the largest 15 
deflection width showed high effect sizes (1.31 and 1.04) however, it was only explored in one 16 
study. Crackle number and two cycle duration presented conflicting information, with high/poor 17 
effect sizes depending on the study. 18 
Conclusion: Specific variables of each adventitious respiratory sound detected and 19 
characterized by computerized respiratory sound analysis showed high effect sizes and thus, 20 
potential to be used as outcome measures. Further research with robust study designs, larger 21 
samples, both of children and adult populations, and following CORSA guidelines are needed to 22 
build evidence base knowledge on this topic. 23 
Key words: computerized respiratory sound analysis; respiratory sounds; adventitious 24 
respiratory sounds; wheezes; crackles; outcome measure  25 
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Introduction 1 
Respiratory diseases are a major cause of societal, health and economic burden worldwide
1
. 2 
Therefore, in the last decade, significant research efforts have been dedicated to improve early 3 
diagnosis and routine monitoring of patients with respiratory diseases to allow timely 4 
interventions. However, this has been found to be highly challenging with the available 5 
respiratory measures (e.g., spirometry, blood gas analysis, imaging techniques), since they are 6 
commonly affected by patient’s motivation and cooperation, are not always available in all 7 
clinical settings and are expensive 
2, 3
. 8 
Computerized respiratory sound analysis, which consists of recording patients’ respiratory 9 
sounds with an electronic device and analyzing them based on specific signal characteristics: is 10 
a simple, objective and non-invasive method to detect and characterize adventitious respiratory 11 
sounds (ARS), i.e., crackle (CR) and wheeze (WH). ARS provide crucial information on 12 
respiratory dysfunction
4
 and changes in their characteristics (intensity, duration, timing, etc.) 13 
might inform the clinical course of respiratory diseases and treatments
5, 6
. Through the use of 14 
computerized respiratory sound analysis, ARS have been found to be a more sensitive 15 
indicator, detecting and characterizing the severity of the respiratory disease before any other 16 
measure
7
. Thus, this approach through the objective data collection and management, 17 
generation of permanent records of the measurements made with easy retrievability and 18 
through graphical representations, assists the diagnosis and monitoring of patients with 19 
respiratory diseases
8-11
. 20 
However, research on this topic has been focusing on the use of computerized respiratory 21 
sound analysis as a diagnostic aid
12
 and the findings reporting its potential to be used as an 22 
outcome measure, i.e., to monitor respiratory treatments, are widespread in the literature. Thus, 23 
this systematic review synthetizes the evidence on the use of computerized ARS as outcome 24 
measures. 25 
Methods 26 
Search strategy 27 
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An electronic literature search was performed from December 2012 to January 2013 in Web of 1 
knowledge (1970-2012), MEDLINE (1948-2012), EMBASE (1974-2012) and SCOPUS (1960-2 
2013) databases. Search terms were based on a combination of the following keywords: 3 
monitor* OR "computerized analyses" OR "digital auscultation" OR "electronic auscultation" OR 4 
"automatic auscultation" OR "acoustic signal processing" AND "added lung sounds" OR 5 
"abnormal lung sounds" OR "adventitious lung sounds" OR "adventitious respiratory sounds" 6 
OR crackle* OR wheez*. The search terms were limited to titles and abstracts. The reference 7 
lists of the selected articles were scanned for other potential eligible studies. Additionally, a 8 
weekly update was conducted until June 2013. This systematic review is reported according to 9 
preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines
13
. 10 
Eligibility criteria  11 
Articles were included if 1) they detected and characterized ARS with computerized respiratory 12 
sound analysis before and after an intervention on adults or children; 2) were experimental, 13 
quasi-experimental or observational studies; 3) were full papers published as original articles or 14 
in conference proceedings and 4) were written in English, Portuguese, Spanish or French. 15 
Articles were excluded if the study was conducted with animals or assessed ARS with 16 
computerized respiratory sound analysis only at one specific moment in time. Book chapters, 17 
review papers, abstracts of communications or meetings, letters to the editor, commentaries to 18 
articles, unpublished work and study protocols were not considered suitable and, therefore, 19 
were also excluded from this review.  20 
Study selection 21 
Duplicates were first removed. Then, the title, abstract and keywords were analyzed to assess 22 
the type and relevance of the publication for the scope of the review. Finally, the full-text of 23 
potentially relevant articles was independently screened for content by the three reviewers to 24 
decide its inclusion in the review. Reviewers resolved disagreements by consensus. 25 
Data extraction 26 
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Data from the included articles were extracted in a structured table-format, i.e.,: first author’s 1 
last name and year of publication, type of study, participants, intervention, data collection 2 
protocol, recording device, data analyses, ARS outcome and findings.  3 
Quality assessment  4 
The quality of the included studies was assessed with the checklist created by Downs and 5 
Black
14
. The checklist provides a list of 27 questions to measure study quality, split into five 6 
sections: reporting (ten items); external validity (three items); internal validity – bias (seven 7 
items); internal validity – confounding (seven items) and power (one item). Similarly to previous 8 
systematic reviews
15, 16
, the scoring for question 27 - dealing with statistical power, was 9 
simplified to a choice of awarding either 1 point or 0 points, depending on whether there was 10 
sufficient power to detect a clinically important effect. Downs and Black score ranges were 11 
grouped into the following 4 quality levels: excellent (26 –28), good (20 –25), fair (15–19), and 12 
poor (≤14)
15, 16
. The risk of bias assessment was carried out by two independent reviewers. 13 
Disagreements between reviewers were resolved by reaching a consensus through discussion.  14 
Data analysis 15 
To determine the consistency of the quality assessment performed by the two reviewers, an 16 
inter-rater agreement analysis using the Cohen’s kappa was performed. The value of Cohen’s 17 
kappa ranges from 0 to 1 and can be categorized as slight (0.0-0.20), fair (0.21-0.40), moderate 18 
(0.41-0.60), substantial (0.61-0.80) or almost perfect (≥0.81) agreement
17
. This statistical 19 
analysis was performed using PASW Statistics (version 18.0, SPSS Inc., Chicago, IL). When 20 
quantitative pooling was appropriate the effect sizes together with the 95% confidence intervals 21 
(95% CI) were computed for the outcomes of interest. The effect sizes (ES) were interpreted as 22 
low (0.20), medium (0.50) and high (0.80) effect magnitudes
18
. This quantitative data analyses 23 
were performed using the meta-analysis software Comprehensive Meta-Analysis (CMA) version 24 
2 (Biostat, Englewood, New Jersey)
19
.  25 
Results 26 
Study selection 27 
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The database search identified 1224 records. After duplicates removal, 900 records were 1 
screened for relevant content. During the title, abstract and keyword screening, 876 articles 2 
were excluded. The full-text of the 24 potentially relevant articles was assessed and 18 articles 3 
were excluded due to the following reasons: ARS detection was performed with standard 4 
auscultation (n=2) or manual annotation (n=4), ARS automatic detection occurred only in one 5 
specific time-point to validate algorithms (n=5), did not provide data on ARS (n=3) and an 6 
intervention was absent (n=4). Six original articles were included in the review. The search for 7 
relevant articles within the reference list of the selected articles retrieved 6 studies which were 8 
also included. 9 
(insert figure 1 about here) 10 
Quality assessment  11 
The articles included in this review scored 10 to 21 on the Downs and Black checklist, with a 12 
mean of 14.42±0.93 (Table 1). Results of the risk of bias assessment indicated that seven 13 
(64%) studies had poor quality, four had fair quality and one good quality. Studies scored 14 
particularly poor on the following items: description of confounders, sample representativeness, 15 
patient blinding, outcome assessor blinding, recruitment, randomization, adjust for confounding 16 
factors in the analysis and power to detect outcomes that are clinically important. The 17 
agreement between two authors was almost perfect (k=0.825; 95% CI 0.758-0.885; p=0.001). 18 
(insert table 1 about here) 19 
Study characteristics 20 
The majority of the included studies were quasi-experimental
5, 20-25
, three were observational
26-28
 21 
and two were randomized controlled trials
29, 30
. Ten studies recruited patients receiving 22 
specialized care and two during hospital admission
24, 27
. A total of 275 subjects (n=126; 45.8% 23 
male) participated in the included studies, 47 were healthy subjects and 208 had respiratory 24 
conditions (Asthma (n=84), Pneumonia (n=11), Cystic fibrosis (n=23), Chronic Obstructive 25 
Pulmonary Disease (COPD) (n=6), prolonged cough (n=28), Bronchiolitis (n=27), 26 
Bronchiectasis (n=23) and Lower Respiratory Tract Infection (LRTI) (n=26)). Eight studies were 27 
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conducted with adults (n=167; 60.7%; age range 21-73 years old)
5, 21, 24-29
 and four with children 1 
(n=108; 39.3%; age range 4 months - 18 years old)
20, 22, 23, 30
. 2 
The interventions of most studies consisted of pharmacotherapy
20-30
, only two studies combined 3 
pharmacotherapy with respiratory physical therapy
5, 29
. The respiratory physical therapy 4 
consisted mainly in active cycle of breathing techniques
5, 29
, but also breathing retraining 5 
techniques; incentive spirometry; thoracic mobility, expansion and flexibility exercises and 6 
aerobic training
29
. In almost all studies, the respiratory sounds were recorded in more than one 7 
chest location however, in three studies recordings were performed exclusively in the trachea
21, 
8 
25, 26
. Only the three more recent studies, acquired the respiratory sounds following the 9 
Computerized Respiratory Sound Analysis (CORSA) guidelines for short-term acquisition
5, 28, 29
. 10 
The recording devices used varied among studies: microphones
21, 24, 25, 27, 29
, piezoelectric 11 
sensors
20, 22, 23, 26, 30
 and electronic stethoscopes
5, 28
. 12 
Algorithms based on Fast Fourier Transformation were the most used to automatically detect 13 
ARS. Two studies used an algorithm based on Short-Time Fourier transformation
28, 29
 and one 14 
used a modification of the algorithm proposed by Shabtai-Musih et al.
31
 and Homs-Corbera et 15 
al
25, 32
. A total of nine studies analyzed WHs (3 were conducted in children), two analyzed CRs
5, 
16 
27
 and one both WHs and CRs in children
30
. Two studies detected breathing cycles 17 
automatically, one used an analogous method reported by Qiu et al
5, 33
 and the other used the 18 
Huq and Moussavi algorithm
30, 34
. Only three studies considered the breathing phases 19 
(inspiration and expiration) in the analysis of the ARS
26, 27, 29
.  20 
(insert table 2 about here) 21 
Synthesis of the results 22 
Wheezes 23 
Presence  24 
The presence of WHs was used to identify a bronchial response during bronchial provocation 25 
tests in two studies conducted with children
20, 22
. Sanchez et al. (1993) used concentrations of 26 
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methacholine and found that WHs had 50% sensitivity and 100% specificity to detect bronchial 1 
hyperreactivity
20
. Bentur et al. (2004) observed that WHs were detected after a mean adenosine 2 
concentration of 15.6mg/ml
22
. Both studies verified that WHs were feasible to assess bronchial 3 
reactivity. 4 
Number 5 
Two studies investigated the number of WHs in adults. Oliveira et al. (2013) found a significant 6 
increase in the number of WHs after 3 weeks of standard medical treatment (6 vs. 14.8; p=0.03; 7 
ES=4.38) in patients with LRTI
28
. A similar result, but not significant, was found in subjects with 8 
stable asthma after terbutaline inhalation (ES=0.34), however in healthy subjects and subjects 9 
with non-stable asthma a non-significant decrease was observed (ES=-0.10 and ES=-0.012, 10 
respectively)
25
. 11 
Frequency  12 
The frequency of WHs was investigated in four studies conducted with adults
21, 25, 28, 29
. After 13 
terbutaline inhalation, the frequency of WHs significantly decreased in patients with asthma 14 
(ES=-0.15), COPD (ES=-0.21) and in healthy subjects (ES=-0.28)
21
. Similar, however non-15 
significant, results were found with the same intervention in healthy subjects (ES=-0.18) and 16 
subjects with non-stable asthma (ES=-0.24)
25
. In subjects with stable asthma (ES=0.01)
25
 and 17 
LRTI (ES=-0.06)
28
 the frequency remained approximately the same. Dinis et al. (2013) 18 
investigated the effect of respiratory physical therapy in subjects with LRTI and observed a non-19 
significant increase in the frequency of inspiratory and expiratory WHs in both experimental 20 
(ES=0.73 and ES=0.04, respectively) and control groups (ES=0.97 and ES=0.97, 21 
respectively)
29
. 22 
Occupation rate 23 
This parameter, which is the proportion of the respiratory cycle occupied by WHs, was explored 24 
in studies conducted with children and adults. In three studies the wheeze occupation rate 25 
(WH%) was used to analyze the effect of pharmacotherapy
24, 25, 30
. A non-significant reduction in 26 
WH% during the night in the group of subjects administered with long-acting sympathomimetic 27 
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agent (ES=-1.9) was found; whereas in the placebo group, a significant increase was observed 1 
(ES=1.15)
24
. In a study conducted with infant viral bronchiolitis, WH% also decreased 10 2 
minutes after the administration of epinephrine (ES=-1.09); however it increased in the group of 3 
children administered with albuterol (ES=1.27)
30
. Nevertheless, no significant differences were 4 
found between or within groups. When exploring monophonic and polyphonic WH% significant 5 
change was also not found however, low effect sizes in non-stable and healthy subjects and 6 
medium effect sizes in subjects with stable asthma (ES=-0.54) were found
25
. A significant 7 
decrease in inspiratory and expiratory WH% was found after 3 weeks of pharmacotherapy plus 8 
respiratory physical therapy (ES=-0.66 (inspiratory); ES=-0.64 (expiratory)) or pharmacotherapy 9 
alone (ES=-0.69 (inspiratory); ES=-0.62 (expiratory))
29
. A similar result was found for the 10 
nocturnal WH index, calculated from the WH% (after 2 days (ES=-0.61) and after 6 weeks 11 
(ES=-0.80)), when monitoring respiratory sounds overnight to assess the effects of montelukast 12 
in nocturnal asthma
23
. 13 
Duration 14 
Two studies explored this variable when assessing the impacts of pharmacotherapy with adult 15 
subjects
26, 28
. In both studies WH duration remained approximately the same pre/post 16 
intervention. Only in subjects with moderate and severe obstruction, changes in the duration of 17 
WHs after medication were observed
26
.  18 
Crackles 19 
Number 20 
Three studies analyzed the number of CRs before and after intervention and no significant 21 
differences were found. In two studies, this variable remained approximately the same, with 22 
effect sizes ranging from 0.02 to 0.22
5, 27
. In the study of Beck et al., the number of CRs 23 
increased (ES=0.58) with albuterol and decreased with epinephrine (ES=-1.65)
30
. 24 
Frequency 25 
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The CR frequency was analyzed only in one study
27
. The peak frequency increased during 1 
inspiration (ES=0.11) and decreased during expiration (ES=-0.47) whereas the upper frequency 2 
at -20-dB level decreased in both inspiration (ES=-0.12) and expiration (ES=-0.35). No 3 
significant differences were found. 4 
Two cycle duration (2CD), Largest deflection width (LDW) and Initial deflection width (IDW) 5 
Two studies analyzed the 2CD variable; Marques et al. did not show any change from pre to 6 
post intervention (ES=0.07)
5
 and Piirila showed a non-significant reduction post intervention 7 
both in inspiratory (ES=-0.85) and expiratory (ES=-0.83) phases
27
. In the study of Piirila, both 8 
LDW and IDW of inspiratory (ES=-1.25 and -0.38) and expiratory (ES=-1 and -0.76) CRs were 9 
shorter after the intervention
27
.  10 
Timing 11 
Only Piirila explored timing parameters of the CRs related to inspiratory tidal volume and 12 
inspiratory and expiratory phases. These parameters were significantly different post 13 
intervention (ES from 0.5 to 1.14) 14 
Due to the heterogeneity of the outcome measures used across studies, a meta-analysis was 15 
not possible to compute. 16 
Discussion 17 
The main finding of this systematic review was that ARS detected and characterized by 18 
computerized respiratory sound analysis show potential to be used as outcome measures in 19 
children and adults, as specific variables of each ARS presented high effect sizes. However, the 20 
most appropriate variable(s) or variables are yet to be explored. 21 
Most studies (11/12) explored WH presence and characteristics before/after an intervention. 22 
Wheeze occupation rate seemed to be the most promising parameter to be used as an outcome 23 
measure in children and adults, with medium to high effect sizes varying from 0.62 to 1.9
24, 29
. A 24 
strong association between the proportion of the respiratory cycle occupied by WHs and the 25 
degree of bronchial obstruction has been widely demonstrated
21-23, 35
. This WH parameter, even 26 
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when identified with standard auscultation, has shown to be sensitive to assess the 1 
effectiveness of respiratory interventions in children
36, 37
. The WH complexity may also be a 2 
variable of interest as the presence of polyphonic WHs indicates a more serious obstruction 3 
than monophonic WHs
25
 however, this was only explored in one study (ES from 0.24 to 0.54)
25
. 4 
Wheeze monitoring has been found to provide more information on the changes of airway 5 
obstruction than measurements of pulmonary function
24
, such as the percentage predicted of 6 
FEV1 in people with asthma
26
. Thus, WHs and their variables seem to be a promising objective 7 
outcome measure for all populations with a special emphasis on non-collaborative populations 8 
such as children, people with dementia and people in the intensive care. However, it should be 9 
noticed that WHs only occur when there is a flow limitation (but flow limitation is not necessarily 10 
accompanied by WHs), that reaches a critical value, called flutter velocity
38
. Thus, when there is 11 
not enough flow to generate WHs, WHs parameters will not be useful despite the presence of 12 
the respiratory problem. The complementary information provided by CRs is therefore, crucial. 13 
Crackles are assumed to be caused by the sudden opening of abnormally closed airways
39-42
, 14 
and their parameters provide essential information about the function and structure of the 15 
tracheobronchial tree
41
, e.g., CR recording during mechanical ventilation has been considered a 16 
simple method to monitor lung recruitment-derecruitment
43
. However, CR variables have been 17 
explored as outcome measures in only three studies
5, 27, 30
. From the limited evidence available, 18 
LDW seemed to be the most valuable parameter to be used as an outcome measure due to its 19 
high effect sizes (1 and 1.25)
27
. Hoevers and Loudon (1990) had already found that LDW 20 
seemed to be a better measure than IDW or 2CD when differentiating between coarse and fine 21 
CRs
44
. However, LDW was also the variable less explored among studies. Conflicting 22 
information was found for the number of CRs and 2CD. The number of CRs had low effect sizes 23 
reported in Piirila (0.14 and 0.22)
27
 and in Marques et al. (0.02)
5
 studies, and medium/high 24 
effect sizes in Beck et al. (0.74 and 1.65)
30
. High (0.83 and 0.85)
27
 and low (0.07)
5
 effect sizes 25 
were also found for the variable 2CD. The timing of CRs (ES 0.5 to 1.14) also showed to be 26 
sensitive to the clinical course of pneumonia
27
 and  has been described as a sensitive 27 
parameter to discriminate respiratory diseases
45
. However, similarly to LDW limited research 28 
has been conducted considering this parameter as an outcome measure. At this point in time it 29 
is difficult to provide any recommendations on which CR’s variable(s) are more adequate to be 30 
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used as an outcome measure to monitor respiratory interventions. These limited and conflicting 1 
data may be a result of the different respiratory sound acquisition sensors (which differ in their 2 
acoustic sensitivity to capture CRs waveforms), filtering and analysis methods used across 3 
studies
46, 47
. Since CRs show potential for diagnosis purposes but also as an outcome measure 4 
for respiratory treatments in different clinical/research contexts, these procedures need to be 5 
standardized. This will allow comparisons among different studies and improve the 6 
understanding of CRs’ mechanisms and acoustic characteristics. 7 
The study of both main types of ARS is essential to gather complementary information about 8 
the tracheobronchial tree. This information may help health professionals to conduct more 9 
accurate diagnosis and enhance their understanding about the respiratory system responses to 10 
treatments. However, only one study analyzed both types of ARS as an outcome measure in a 11 
study conducted with children
30
. Thus, the study of computerized ARS is an exciting area where 12 
much research is needed to develop knowledge for diagnosis and monitoring of patients but 13 
also to be used as a non-invasive, objective and reliable outcome measure for treatments. 14 
The level of evidence that can be drawn at this moment in time from this systematic review is 15 
considerably weak due to the 1) small sample sizes; 2) distinct respiratory therapies and doses 16 
implemented and 3) different ARS variables used in the included studies. The large variety of 17 
acquisition methods used is an issue added to the list of difficulties when comparing results 18 
across studies. A BIOMED 1 Concerted Action project entitled CORSA, funded by the European 19 
Community, developed guidelines for research and clinical practice in the field of respiratory 20 
sound acquisition and analysis
4, 9, 48
. The CORSA project group produced guidelines on the 21 
definitions of medical/technical terms used in pulmonary acoustics; environmental conditions; 22 
patient management procedures; acquisition, pre-processing, digitization and analysis of 23 
respiratory sounds; and also about publishing the results of research
4, 9, 48
. These international 24 
guidelines have been available since 2000, however from the 9 studies conducted after this 25 
year, only 3 followed the acquisition procedures recommended by CORSA. Regarding the 26 
analysis methods, algorithms based on Fast Fourier Transformation were the most used, which 27 
is in accordance with the CORSA recommendations. Future research, with improved study 28 
designs, larger samples, both of children and adult populations, and following the CORSA 29 
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guidelines, should be conducted to explore the ARS response to respiratory therapies. This will 1 
facilitate the comparison of results from different studies, promote research into the 2 
development of standardized respiratory sound acquisition equipment and analysis and finally 3 
enhance the understanding of computerized ARS as well as their use as an outcome measure. 4 
Conclusion 5 
Specific variables of each ARS detected and characterized with computerized respiratory sound 6 
analysis showed high effect sizes and thus may have potential to be an objective, reliable and 7 
non-invasive outcome measure for respiratory therapy in children and adults.  Further research 8 
exploring the ARS response to different respiratory therapies are needed to enhance the 9 
understanding of computerized ARS and their clinical use not only for the diagnosis purposes 10 
but also for monitoring patients and treatments. 11 
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Abstract 1 
Introduction: There is a need to develop simple, non-invasive and sensitive outcome measures 2 
for respiratory therapy. Adventitious respiratory sounds (i.e., crackles and wheezes) can be 3 
objectively characterized with computerized respiratory sound analysis and have been shown to 4 
contribute for diagnosis purposes however; their potential to be used as outcome measures is 5 
unknown. Thus, this systematic review synthetizes the evidence on the use of computerized 6 
adventitious respiratory sounds as outcome measures. 7 
Methods: The Web of knowledge, MEDLINE, EMBASE and SCOPUS databases were 8 
searched. Reviewers independently selected studies according to the eligibility criteria. Effect 9 
sizes and 95% confidence intervals were computed. 10 
Results: Twelve studies with different designs (observational (n=3), quasi-experimental (n=7) 11 
and randomized controlled trial (n=2)) were included. Eight studies were conducted with adults 12 
and four with children. Most studies explored only one type of adventitious respiratory sound. 13 
For wheezes, the occupation rate seemed to be the most promising parameter to be used as an 14 
outcome measure, with high/medium effect sizes (from 0.62 to 1.82). For crackles, the largest 15 
deflection width showed high effect sizes (1.31 and 1.04) however, it was only explored in one 16 
study. Crackle number and two cycle duration presented conflicting information, with high/poor 17 
effect sizes depending on the study. 18 
Conclusion: Specific variables of each adventitious respiratory sound detected and 19 
characterized by computerized respiratory sound analysis showed high effect sizes and thus, 20 
potential to be used as outcome measures. Further research with robust study designs, larger 21 
samples, both of children and adult populations, and following CORSA guidelines are needed to 22 
build evidence base knowledge on this topic. 23 
Key words: computerized respiratory sound analysis; respiratory sounds; adventitious 24 
respiratory sounds; wheezes; crackles; outcome measure  25 
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Introduction 1 
Respiratory diseases are a major cause of societal, health and economic burden worldwide
1
. 2 
Therefore, in the last decade, significant research efforts have been dedicated to improve early 3 
diagnosis and routine monitoring of patients with respiratory diseases to allow timely 4 
interventions. However, this has been found to be highly challenging with the available 5 
respiratory measures (e.g., spirometry, blood gas analysis, imaging techniques), since they are 6 
commonly affected by patient’s motivation and cooperation, are not always available in all 7 
clinical settings and are expensive 
2, 3
. 8 
Computerized respiratory sound analysis, which consists of recording patients’ respiratory 9 
sounds with an electronic device and analyzing them based on specific signal characteristics: is 10 
a simple, objective and non-invasive method to detect and characterize adventitious respiratory 11 
sounds (ARS), i.e., crackle (CR) and wheeze (WH). ARS provide crucial information on 12 
respiratory dysfunction
4
 and changes in their characteristics (intensity, duration, timing, etc.) 13 
might inform the clinical course of respiratory diseases and treatments
5, 6
. Through the use of 14 
computerized respiratory sound analysis, ARS have been found to be a more sensitive 15 
indicator, detecting and characterizing the severity of the respiratory disease before any other 16 
measure
7
. Thus, this approach through the objective data collection and management, 17 
generation of permanent records of the measurements made with easy retrievability and 18 
through graphical representations, assists the diagnosis and monitoring of patients with 19 
respiratory diseases
8-11
. 20 
However, research on this topic has been focusing on the use of computerized respiratory 21 
sound analysis as a diagnostic aid
12
 and the findings reporting its potential to be used as an 22 
outcome measure, i.e., to monitor respiratory treatments, are widespread in the literature. Thus, 23 
this systematic review synthetizes the evidence on the use of computerized ARS as outcome 24 
measures. 25 
Methods 26 
Search strategy 27 
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An electronic literature search was performed from December 2012 to January 2013 in Web of 1 
knowledge (1970-2012), MEDLINE (1948-2012), EMBASE (1974-2012) and SCOPUS (1960-2 
2013) databases. Search terms were based on a combination of the following keywords: 3 
monitor* OR "computerized analyses" OR "digital auscultation" OR "electronic auscultation" OR 4 
"automatic auscultation" OR "acoustic signal processing" AND "added lung sounds" OR 5 
"abnormal lung sounds" OR "adventitious lung sounds" OR "adventitious respiratory sounds" 6 
OR crackle* OR wheez*. The search terms were limited to titles and abstracts. The reference 7 
lists of the selected articles were scanned for other potential eligible studies. Additionally, a 8 
weekly update was conducted until June 2013. This systematic review is reported according to 9 
preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines
13
. 10 
Eligibility criteria  11 
Articles were included if 1) they detected and characterized ARS with computerized respiratory 12 
sound analysis before and after an intervention on adults or children; 2) were experimental, 13 
quasi-experimental or observational studies; 3) were full papers published as original articles or 14 
in conference proceedings and 4) were written in English, Portuguese, Spanish or French. 15 
Articles were excluded if the study was conducted with animals or assessed ARS with 16 
computerized respiratory sound analysis only at one specific moment in time. Book chapters, 17 
review papers, abstracts of communications or meetings, letters to the editor, commentaries to 18 
articles, unpublished work and study protocols were not considered suitable and, therefore, 19 
were also excluded from this review.  20 
Study selection 21 
Duplicates were first removed. Then, the title, abstract and keywords were analyzed to assess 22 
the type and relevance of the publication for the scope of the review. Finally, the full-text of 23 
potentially relevant articles was independently screened for content by the three reviewers to 24 
decide its inclusion in the review. Reviewers resolved disagreements by consensus. 25 
Data extraction 26 
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Data from the included articles were extracted in a structured table-format, i.e.,: first author’s 1 
last name and year of publication, type of study, participants, intervention, data collection 2 
protocol, recording device, data analyses, ARS outcome and findings.  3 
Quality assessment  4 
The quality of the included studies was assessed with the checklist created by Downs and 5 
Black
14
. The checklist provides a list of 27 questions to measure study quality, split into five 6 
sections: reporting (ten items); external validity (three items); internal validity – bias (seven 7 
items); internal validity – confounding (seven items) and power (one item). Similarly to previous 8 
systematic reviews
15, 16
, the scoring for question 27 - dealing with statistical power, was 9 
simplified to a choice of awarding either 1 point or 0 points, depending on whether there was 10 
sufficient power to detect a clinically important effect. Downs and Black score ranges were 11 
grouped into the following 4 quality levels: excellent (26 –28), good (20 –25), fair (15–19), and 12 
poor (≤14)
15, 16
. The risk of bias assessment was carried out by two independent reviewers. 13 
Disagreements between reviewers were resolved by reaching a consensus through discussion.  14 
Data analysis 15 
To determine the consistency of the quality assessment performed by the two reviewers, an 16 
inter-rater agreement analysis using the Cohen’s kappa was performed. The value of Cohen’s 17 
kappa ranges from 0 to 1 and can be categorized as slight (0.0-0.20), fair (0.21-0.40), moderate 18 
(0.41-0.60), substantial (0.61-0.80) or almost perfect (≥0.81) agreement
17
. This statistical 19 
analysis was performed using PASW Statistics (version 18.0, SPSS Inc., Chicago, IL). When 20 
quantitative pooling was appropriate the effect sizes together with the 95% confidence intervals 21 
(95% CI) were computed for the outcomes of interest. The effect sizes (ES) were interpreted as 22 
low (0.20), medium (0.50) and high (0.80) effect magnitudes
18
. This quantitative data analyses 23 
were performed using the meta-analysis software Comprehensive Meta-Analysis (CMA) version 24 
2 (Biostat, Englewood, New Jersey)
19
.  25 
Results 26 
Study selection 27 
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The database search identified 1224 records. After duplicates removal, 900 records were 1 
screened for relevant content. During the title, abstract and keyword screening, 876 articles 2 
were excluded. The full-text of the 24 potentially relevant articles was assessed and 18 articles 3 
were excluded due to the following reasons: ARS detection was performed with standard 4 
auscultation (n=2) or manual annotation (n=4), ARS automatic detection occurred only in one 5 
specific time-point to validate algorithms (n=5), did not provide data on ARS (n=3) and an 6 
intervention was absent (n=4). Six original articles were included in the review. The search for 7 
relevant articles within the reference list of the selected articles retrieved 6 studies which were 8 
also included. 9 
(insert figure 1 about here) 10 
Quality assessment  11 
The articles included in this review scored 10 to 21 on the Downs and Black checklist, with a 12 
mean of 14.42±0.93 (Table 1). Results of the risk of bias assessment indicated that seven 13 
(64%) studies had poor quality, four had fair quality and one good quality. Studies scored 14 
particularly poor on the following items: description of confounders, sample representativeness, 15 
patient blinding, outcome assessor blinding, recruitment, randomization, adjust for confounding 16 
factors in the analysis and power to detect outcomes that are clinically important. The 17 
agreement between two authors was almost perfect (k=0.825; 95% CI 0.758-0.885; p=0.001). 18 
(insert table 1 about here) 19 
Study characteristics 20 
The majority of the included studies were quasi-experimental
5, 20-25
, three were observational
26-28
 21 
and two were randomized controlled trials
29, 30
. Ten studies recruited patients receiving 22 
specialized care and two during hospital admission
24, 27
. A total of 275 subjects (n=126; 45.8% 23 
male) participated in the included studies, 47 were healthy subjects and 208 had respiratory 24 
conditions (Asthma (n=84), Pneumonia (n=11), Cystic fibrosis (n=23), Chronic Obstructive 25 
Pulmonary Disease (COPD) (n=6), prolonged cough (n=28), Bronchiolitis (n=27), 26 
Bronchiectasis (n=23) and Lower Respiratory Tract Infection (LRTI) (n=26)). Eight studies were 27 
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conducted with adults (n=167; 60.7%; age range 21-73 years old)
5, 21, 24-29
 and four with children 1 
(n=108; 39.3%; age range 4 months - 18 years old)
20, 22, 23, 30
. 2 
The interventions of most studies consisted of pharmacotherapy
20-30
, only two studies combined 3 
pharmacotherapy with respiratory physical therapy
5, 29
. The respiratory physical therapy 4 
consisted mainly in active cycle of breathing techniques
5, 29
, but also breathing retraining 5 
techniques; incentive spirometry; thoracic mobility, expansion and flexibility exercises and 6 
aerobic training
29
. In almost all studies, the respiratory sounds were recorded in more than one 7 
chest location however, in three studies recordings were performed exclusively in the trachea
21, 
8 
25, 26
. Only the three more recent studies, acquired the respiratory sounds following the 9 
Computerized Respiratory Sound Analysis (CORSA) guidelines for short-term acquisition
5, 28, 29
. 10 
The recording devices used varied among studies: microphones
21, 24, 25, 27, 29
, piezoelectric 11 
sensors
20, 22, 23, 26, 30
 and electronic stethoscopes
5, 28
. 12 
Algorithms based on Fast Fourier Transformation were the most used to automatically detect 13 
ARS. Two studies used an algorithm based on Short-Time Fourier transformation
28, 29
 and one 14 
used a modification of the algorithm proposed by Shabtai-Musih et al.
31
 and Homs-Corbera et 15 
al
25, 32
. A total of nine studies analyzed WHs (3 were conducted in children), two analyzed CRs
5, 
16 
27
 and one both WHs and CRs in children
30
. Two studies detected breathing cycles 17 
automatically, one used an analogous method reported by Qiu et al
5, 33
 and the other used the 18 
Huq and Moussavi algorithm
30, 34
. Only three studies considered the breathing phases 19 
(inspiration and expiration) in the analysis of the ARS
26, 27, 29
.  20 
(insert table 2 about here) 21 
Synthesis of the results 22 
Wheezes 23 
Presence  24 
The presence of WHs was used to identify a bronchial response during bronchial provocation 25 
tests in two studies conducted with children
20, 22
. Sanchez et al. (1993) used concentrations of 26 
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methacholine and found that WHs had 50% sensitivity and 100% specificity to detect bronchial 1 
hyperreactivity
20
. Bentur et al. (2004) observed that WHs were detected after a mean adenosine 2 
concentration of 15.6mg/ml
22
. Both studies verified that WHs were feasible to assess bronchial 3 
reactivity. 4 
Number 5 
Two studies investigated the number of WHs in adults. Oliveira et al. (2013) found a significant 6 
increase in the number of WHs after 3 weeks of standard medical treatment (6 vs. 14.8; p=0.03; 7 
ES=4.38) in patients with LRTI
28
. A similar result, but not significant, was found in subjects with 8 
stable asthma after terbutaline inhalation (ES=0.34), however in healthy subjects and subjects 9 
with non-stable asthma a non-significant decrease was observed (ES=-0.10 and ES=-0.012, 10 
respectively)
25
. 11 
Frequency  12 
The frequency of WHs was investigated in four studies conducted with adults
21, 25, 28, 29
. After 13 
terbutaline inhalation, the frequency of WHs significantly decreased in patients with asthma 14 
(ES=-0.15), COPD (ES=-0.21) and in healthy subjects (ES=-0.28)
21
. Similar, however non-15 
significant, results were found with the same intervention in healthy subjects (ES=-0.18) and 16 
subjects with non-stable asthma (ES=-0.24)
25
. In subjects with stable asthma (ES=0.01)
25
 and 17 
LRTI (ES=-0.06)
28
 the frequency remained approximately the same. Dinis et al. (2013) 18 
investigated the effect of respiratory physical therapy in subjects with LRTI and observed a non-19 
significant increase in the frequency of inspiratory and expiratory WHs in both experimental 20 
(ES=0.73 and ES=0.04, respectively) and control groups (ES=0.97 and ES=0.97, 21 
respectively)
29
. 22 
Occupation rate 23 
This parameter, which is the proportion of the respiratory cycle occupied by WHs, was explored 24 
in studies conducted with children and adults. In three studies the wheeze occupation rate 25 
(WH%) was used to analyze the effect of pharmacotherapy
24, 25, 30
. A non-significant reduction in 26 
WH% during the night in the group of subjects administered with long-acting sympathomimetic 27 
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agent (ES=-1.9) was found; whereas in the placebo group, a significant increase was observed 1 
(ES=1.15)
24
. In a study conducted with infant viral bronchiolitis, WH% also decreased 10 2 
minutes after the administration of epinephrine (ES=-1.09); however it increased in the group of 3 
children administered with albuterol (ES=1.27)
30
. Nevertheless, no significant differences were 4 
found between or within groups. When exploring monophonic and polyphonic WH% significant 5 
change was also not found however, low effect sizes in non-stable and healthy subjects and 6 
medium effect sizes in subjects with stable asthma (ES=-0.54) were found
25
. A significant 7 
decrease in inspiratory and expiratory WH% was found after 3 weeks of pharmacotherapy plus 8 
respiratory physical therapy (ES=-0.66 (inspiratory); ES=-0.64 (expiratory)) or pharmacotherapy 9 
alone (ES=-0.69 (inspiratory); ES=-0.62 (expiratory))
29
. A similar result was found for the 10 
nocturnal WH index, calculated from the WH% (after 2 days (ES=-0.61) and after 6 weeks 11 
(ES=-0.80)), when monitoring respiratory sounds overnight to assess the effects of montelukast 12 
in nocturnal asthma
23
. 13 
Duration 14 
Two studies explored this variable when assessing the impacts of pharmacotherapy with adult 15 
subjects
26, 28
. In both studies WH duration remained approximately the same pre/post 16 
intervention. Only in subjects with moderate and severe obstruction, changes in the duration of 17 
WHs after medication were observed
26
.  18 
Crackles 19 
Number 20 
Three studies analyzed the number of CRs before and after intervention and no significant 21 
differences were found. In two studies, this variable remained approximately the same, with 22 
effect sizes ranging from 0.02 to 0.22
5, 27
. In the study of Beck et al., the number of CRs 23 
increased (ES=0.58) with albuterol and decreased with epinephrine (ES=-1.65)
30
. 24 
Frequency 25 
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The CR frequency was analyzed only in one study
27
. The peak frequency increased during 1 
inspiration (ES=0.11) and decreased during expiration (ES=-0.47) whereas the upper frequency 2 
at -20-dB level decreased in both inspiration (ES=-0.12) and expiration (ES=-0.35). No 3 
significant differences were found. 4 
Two cycle duration (2CD), Largest deflection width (LDW) and Initial deflection width (IDW) 5 
Two studies analyzed the 2CD variable; Marques et al. did not show any change from pre to 6 
post intervention (ES=0.07)
5
 and Piirila showed a non-significant reduction post intervention 7 
both in inspiratory (ES=-0.85) and expiratory (ES=-0.83) phases
27
. In the study of Piirila, both 8 
LDW and IDW of inspiratory (ES=-1.25 and -0.38) and expiratory (ES=-1 and -0.76) CRs were 9 
shorter after the intervention
27
.  10 
Timing 11 
Only Piirila explored timing parameters of the CRs related to inspiratory tidal volume and 12 
inspiratory and expiratory phases. These parameters were significantly different post 13 
intervention (ES from 0.5 to 1.14) 14 
Due to the heterogeneity of the outcome measures used across studies, a meta-analysis was 15 
not possible to compute. 16 
Discussion 17 
The main finding of this systematic review was that ARS detected and characterized by 18 
computerized respiratory sound analysis show potential to be used as outcome measures in 19 
children and adults, as specific variables of each ARS presented high effect sizes. However, the 20 
most appropriate variable(s) or variables are yet to be explored. 21 
Most studies (11/12) explored WH presence and characteristics before/after an intervention. 22 
Wheeze occupation rate seemed to be the most promising parameter to be used as an outcome 23 
measure in children and adults, with medium to high effect sizes varying from 0.62 to 1.9
24, 29
. A 24 
strong association between the proportion of the respiratory cycle occupied by WHs and the 25 
degree of bronchial obstruction has been widely demonstrated
21-23, 35
. This WH parameter, even 26 
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when identified with standard auscultation, has shown to be sensitive to assess the 1 
effectiveness of respiratory interventions in children
36, 37
. The WH complexity may also be a 2 
variable of interest as the presence of polyphonic WHs indicates a more serious obstruction 3 
than monophonic WHs
25
 however, this was only explored in one study (ES from 0.24 to 0.54)
25
. 4 
Wheeze monitoring has been found to provide more information on the changes of airway 5 
obstruction than measurements of pulmonary function
24
, such as the percentage predicted of 6 
FEV1 in people with asthma
26
. Thus, WHs and their variables seem to be a promising objective 7 
outcome measure for all populations with a special emphasis on non-collaborative populations 8 
such as children, people with dementia and people in the intensive care. However, it should be 9 
noticed that WHs only occur when there is a flow limitation (but flow limitation is not necessarily 10 
accompanied by WHs), that reaches a critical value, called flutter velocity
38
. Thus, when there is 11 
not enough flow to generate WHs, WHs parameters will not be useful despite the presence of 12 
the respiratory problem. The complementary information provided by CRs is therefore, crucial. 13 
Crackles are assumed to be caused by the sudden opening of abnormally closed airways
39-42
, 14 
and their parameters provide essential information about the function and structure of the 15 
tracheobronchial tree
41
, e.g., CR recording during mechanical ventilation has been considered a 16 
simple method to monitor lung recruitment-derecruitment
43
. However, CR variables have been 17 
explored as outcome measures in only three studies
5, 27, 30
. From the limited evidence available, 18 
LDW seemed to be the most valuable parameter to be used as an outcome measure due to its 19 
high effect sizes (1 and 1.25)
27
. Hoevers and Loudon (1990) had already found that LDW 20 
seemed to be a better measure than IDW or 2CD when differentiating between coarse and fine 21 
CRs
44
. However, LDW was also the variable less explored among studies. Conflicting 22 
information was found for the number of CRs and 2CD. The number of CRs had low effect sizes 23 
reported in Piirila (0.14 and 0.22)
27
 and in Marques et al. (0.02)
5
 studies, and medium/high 24 
effect sizes in Beck et al. (0.74 and 1.65)
30
. High (0.83 and 0.85)
27
 and low (0.07)
5
 effect sizes 25 
were also found for the variable 2CD. The timing of CRs (ES 0.5 to 1.14) also showed to be 26 
sensitive to the clinical course of pneumonia
27
 and  has been described as a sensitive 27 
parameter to discriminate respiratory diseases
45
. However, similarly to LDW limited research 28 
has been conducted considering this parameter as an outcome measure. At this point in time it 29 
is difficult to provide any recommendations on which CR’s variable(s) are more adequate to be 30 
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used as an outcome measure to monitor respiratory interventions. These limited and conflicting 1 
data may be a result of the different respiratory sound acquisition sensors (which differ in their 2 
acoustic sensitivity to capture CRs waveforms), filtering and analysis methods used across 3 
studies
46, 47
. Since CRs show potential for diagnosis purposes but also as an outcome measure 4 
for respiratory treatments in different clinical/research contexts, these procedures need to be 5 
standardized. This will allow comparisons among different studies and improve the 6 
understanding of CRs’ mechanisms and acoustic characteristics. 7 
The study of both main types of ARS is essential to gather complementary information about 8 
the tracheobronchial tree. This information may help health professionals to conduct more 9 
accurate diagnosis and enhance their understanding about the respiratory system responses to 10 
treatments. However, only one study analyzed both types of ARS as an outcome measure in a 11 
study conducted with children
30
. Thus, the study of computerized ARS is an exciting area where 12 
much research is needed to develop knowledge for diagnosis and monitoring of patients but 13 
also to be used as a non-invasive, objective and reliable outcome measure for treatments. 14 
The level of evidence that can be drawn at this moment in time from this systematic review is 15 
considerably weak due to the 1) small sample sizes; 2) distinct respiratory therapies and doses 16 
implemented and 3) different ARS variables used in the included studies. The large variety of 17 
acquisition methods used is an issue added to the list of difficulties when comparing results 18 
across studies. A BIOMED 1 Concerted Action project entitled CORSA, funded by the European 19 
Community, developed guidelines for research and clinical practice in the field of respiratory 20 
sound acquisition and analysis
4, 9, 48
. The CORSA project group produced guidelines on the 21 
definitions of medical/technical terms used in pulmonary acoustics; environmental conditions; 22 
patient management procedures; acquisition, pre-processing, digitization and analysis of 23 
respiratory sounds; and also about publishing the results of research
4, 9, 48
. These international 24 
guidelines have been available since 2000, however from the 9 studies conducted after this 25 
year, only 3 followed the acquisition procedures recommended by CORSA. Regarding the 26 
analysis methods, algorithms based on Fast Fourier Transformation were the most used, which 27 
is in accordance with the CORSA recommendations. Future research, with improved study 28 
designs, larger samples, both of children and adult populations, and following the CORSA 29 
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guidelines, should be conducted to explore the ARS response to respiratory therapies. This will 1 
facilitate the comparison of results from different studies, promote research into the 2 
development of standardized respiratory sound acquisition equipment and analysis and finally 3 
enhance the understanding of computerized ARS as well as their use as an outcome measure. 4 
Conclusion 5 
Specific variables of each ARS detected and characterized with computerized respiratory sound 6 
analysis showed high effect sizes and thus may have potential to be an objective, reliable and 7 
non-invasive outcome measure for respiratory therapy in children and adults.  Further research 8 
exploring the ARS response to different respiratory therapies are needed to enhance the 9 
understanding of computerized ARS and their clinical use not only for the diagnosis purposes 10 
but also for monitoring patients and treatments. 11 
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Figure captions 1 
Figure 1 - PRISMA Flowshart of the included studies. 2 
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Table 1 - Quality assessment score for selected studies based on the Downs and Black checklist. 
 
MS, maximum score. 
 
Study (year) Reporting 
MS=11 
External validity 
MS=3 
Internal validity – bias 
MS=7 
Internal validity - 
confounding  
MS=6 
Power 
MS=1 
Total Score 
Baughman & Loudon (1988) 5 0 6 1 0 12 
Piirila (1992) 7 1 3 2 0 13 
Sanchez et al. (1993) 6 1 4 0 0 11 
Fiz et al. (2002) 7 0 5 0 0 12 
Bentur et al. (2003) 8 0 4 1 0 13 
Bentur et al. (2004) 8 2 5 2 1 18 
Cortes et al. (2005) 6 1 1 2 0 10 
Fiz et al.  (2006) 8 0 5 3 0 16 
Beck et al. (2007) 8 1 7 5 0 21 
Marques et al. (2012) 8 1 5 2 0 16 
Oliveira et al. (2013) 7 1 4 2 0 14 
Dinis et al. (2013) 8 1 5 3 0 17 
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   Table 2 – Characteristics of the adventitious respiratory sounds pre-post intervention. 
Study 
(Year) 
Type of study Participants Intervention Data collection protocol Recording Device Data Analyses ALS 
outcomes  
Findings 
Baughman 
& Loudon 
(1988) 
Quasi-
Experimental 
10 subjects 
with 
nocturnal 
asthma 
One night Placebo 
One night Long-
acting β2-
sympathomimetic 
agent – procaterol 
(0.1mg) 
 
 
Respiratory sound recordings: 
- night monitoring of wheezing after 
intervention at 12am and at 4am; 
- 6 segments of  5 minutes recordings at 
each assessment; 
- microphone of an accelerometer placed 
over the cricopharynx; 
- stethoscope over the right anterior 
chest. 
Modified 
stethoscope air-
coupled to a 
microphone. 
WHs detection: 
FFT 
Analyses for the 
presence/ absence 
of a peak at a 
frequency 150- 
1,000Hz.  
WH% 
 
Placebo 
WH%: 12AM 18±5.3%; 4AM 24.8±6.4%; p<0.05 
(ES=1.15) 
Procaterol 
WH%: 12AM 23.2±6.9%; 4AM 11.8 ±4.0% (ES=-1.9) 
 
 
Piirila 
(1992) 
Observational 11 subjects 
with 
pneumonia 
21-71yrs 
6M:5F 
Standard medical 
treatment 
 
Respiratory sound recordings: 
- 2.2±1.1 days after hospital presentation 
and then after 2.7±1.0 days; 
- subjects in a sitting position, breathing 
with a maximum flow of 1L/s; 
- 5 complete respiratory cycles; 
- basal regions of both lungs. 
 
 
 
Air-coupled 
condenser 
microphones 
CR detection: 
Phonopneumograph
y 
FFT 
TEW 
Automatic CR 
counter 
CR: 
N 
IDW 
2CD 
LDW 
Beginning  
Duration  
End point 
PF 
Fu 
Ie 
Inspiratory CR 
N: Pre 5±1.9; Post 6± 5.3 (ES=0.22) 
IDW: Pre1.5±0.2ms; Post 1.4±0.3ms (ES=-0.38) 
2CD: Pre 10.1±1.3ms; Post 8.6±2ms (ES=-0.85) 
LDW: Pre 2.6±0.4ms; Post 2.1±0.4ms; p<0.05 (ES=-
1.25) 
Beginning: Pre 35±16%Vt; Post 53±19%Vt; p<0.01 
(ES=1.02) 
Duration: Pre 35±13%Ti; Post 36±8%Ti (ES=0.09) 
End point: Pre 72±13%Vt; Post 83±14%Vt (ES=0.81) 
End point: Pre 69±11%Ti; Post 81±10%Ti; p<0.05 
(ES=1.14) 
PF: Pre 156±46Hz; Post 161±42Hz (ES=0.11) 
Fu: Pre 437±71Hz; Post 426±106Hz (ES=-0.12) 
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Ie: Pre 0.64±0.34V; Post 0.50±0.23V (ES=-0.47) 
Expiratory CR 
N: Pre 0.8±0.8; Post 0.7±0.14 (ES=-0.14) 
IDW: Pre1.7±0.4ms; Post1.3±0.6ms (ES=-0.76) 
2CD: Pre 11.9±2.4ms; Post 8.1±5.3ms (ES=-0.83) 
LDW: Pre 3±0.6ms; Post 2.4±0.6ms (ES=-1) 
Beginning: Pre 56±14%Te; Post 63±14%Te (ES=0.5) 
Duration: Pre 46±39%Te; Post 22±0%Te (ES=-0.62) 
End point: Pre 79±23%Te; Post 95±0%Te (ES=0.7) 
PF: Pre 126±42Hz; Post 109±22Hz (ES=-0.47) 
Fu: Pre 365±127Hz; Post 327±69Hz (ES=-0.35) 
Sanchez et 
al. 
(1993) 
Quasi-
Experimental 
EG: 23 
children with 
cystic fibrosis 
4-18yrs 
14M:9F 
CG: 18 
healthy 
children 
4-16yrs 
7M:11F 
Methacholine 
challenge: doubling 
concentrations of 
methacholine 
nebulized for 2 min 
(start 0.03mg/ml) 
Respiratory sound recordings:  
- 1min after each dose;  
- spontaneous breathing; 
- sounds at trachea and posterior right 
lower lobe recorded simultaneously. 
Piezoelectric 
accelerometers 
WHs detection: 
FFT 
Based on PF 
(auditory 
verification on 
digital-to-analog 
playback) 
Presence of 
WHs 
WH as an indicator of bronchial hyperreactivity: 
Se:50% 
Sp:100% 
Fiz et al. 
(2002) 
Quasi-
Experimental 
EG1: 16 
subjects with 
asthma 
53.6±16.3yrs 
9M:7F 
Inhalation of  
terbutaline (1mg) 
Respiratory sound recordings:  
- acquired before and 20min after the 
intervention; 
- FVC maneuvers; 
- at the trachea. 
Contact 
microphone  
WHs detection: 
FFT 
Modified version of 
the Shabtai-Musih 
et al. algorithm 
WH 
frequency 
 
EG1 
F: Pre 560.9±140.8Hz; Post 538.4±160.5Hz; p<0.01 
(ES=-0.15) 
EG2 
F: Pre 669.4±250.1Hz; Post 620.6±208.9Hz; p<0.01 
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EG2:6 
subjects with 
COPD 
58.8±4.9yrs 
6M:0F 
CG: 15 
healthy 
subjects 
45.8±12.5yrs 
7M:8F 
 (ES=-0.21) 
CG 
F: Pre 750.7±175.7; Post 701.6±170.1; p<0.01 (ES=-
0.28) 
 
Bentur et 
al. 
(2003) 
Quasi-
Experimental 
12 children 
with asthma 
6-14yrs 
6M:6F 
 
Montelukast daily 
(5mg) 
Respiratory sound recordings:  
- overnight (8h) monitoring of wheezing 
before the intervention (Pre), after 48 
hours (Post 1) and after 6 weeks (Post2); 
- at the trachea, right and left axillae and 
both posterior bases of the lungs. 
Phonopneumogra
phy piezoelectric 
contact sensors 
connected to an 
automatic WH 
detection device 
WHs detection: 
FFT based algorithm  
 
NWI NWI: Pre 814±898; Post1 318±199; p=0.05 (ES=-0.61) 
Post2 137±101; p=0.028 (ES=-0.80) 
Bentur et 
al. 
(2004) 
Quasi-
Experimental 
28 children 
with 
prolonged 
cough  
8.3±4.3mont
hs 
19M:9F  
Acoustic Brochial 
Provocation tests: 
Nebulized 
adenosine solutions 
(start 0.39 mg/ml) 
inhaled for 2 min; 
dose doubled at 
5min intervals 
Respiratory sound recordings:  
- after each 2 min of inhalation; 
- records of 30s; 
- at the trachea, the axilla right, and the 
axilla left, and both posterior bases of the 
lungs. 
Phonopneumogra
phy piezoelectric 
contact sensors 
connected to an 
automatic WH 
detection device  
WHs detection:  
FFT based algorithm 
(an auditory audit of 
the data was 
performed to verify 
the detection 
accuracy) 
Presence of 
WHs 
Presence of WHs: 
-at 15.6±25.2(0.78-100)mg/mL of adenosine 
concentration 
- at an adenosine concentration ≤25mg/mL in 85% of 
the subjects with positive BPT  
Cortes et 
al. 
Observational G1:10 
subjects with 
Bronchodilator 
inhalation drug 
Respiratory sound recordings: 
- acquired before and after 20 minutes of 
Phonopneumogra
phy piezoelectric  
WHs detection: 
Frequency analysis 
WH 
duration 
G1 
Inspiration: Post duration similar to Pre duration 
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(2005) asthma 
(FEV1<50%) 
42±17yrs 
G2: 11 
subjects with 
asthma 
(50%<FEV1<8
0%) 
42.2±9.7yrs 
G3: 5 subjects 
with asthma 
(FEV1>80%) 
29.2±8.7yrs 
the intervention; 
- spontaneous breathing; 
- 2 records of 120s; 
- at the trachea. 
sensor 
 
 Expiration: Post duration similar to Pre duration 
G2 
Inspiration: Post duration < Pre duration 
Expiration: Post duration < Pre duration 
G3 
Inspiration: Post duration similar to Pre duration 
Expiration: Post duration > Pre duration 
Fiz et al. 
(2006) 
Quasi-
Experimental 
G1: 11 
subjects with 
non-stable 
asthma 
54±15.7yrs 
8M:3F 
G2: 9 subjects 
with stable 
asthma 
46±12.6yrs 
6M:3F 
CG3: 14 
healthy 
Bronchodilator 
inhalation drug 
(terbutaline - 1mg) 
 
Respiratory sound recordings: 
- acquired before and after 20 minutes of 
the intervention; 
- FVC maneuvers; 
- at the trachea. 
Phonopneumogra
phy 
contact 
microphone 
WHs detection: 
modification of the 
algorithm proposed 
by Shabtai-Musih et 
al. and Homs-
Corbera 
et al. 
WH 
N 
F 
WH% 
monophoni
c 
WH% 
polyphonic 
 
G1 
N: Pre 13.6±13.3; Post 13.4±19.6 (ES=-0.01) 
F: Pre 542.7±185.3Hz; Post 527±62Hz (ES=-0.1)  
WH% monophonic: Pre 52.5±21.6%; Post 47.7±19% 
(ES=-0.24) 
WH% polyphonic: Pre 38.2±25.4%; Post 29.9±23.5% 
(ES=-0.34) 
G2 
N: Pre 3.5±3; Post 5.5±6.8 (ES=0.34) 
F: Pre 582.2±226.9Hz; Post 583.3±216.5Hz (ES=0.01)  
WH% monophonic: Pre 27.0±13.4%; Post 19.4±14.9% 
(ES=-0.54) 
WH% polyphonic: Pre 16±21.4%; Post 25.2±30.1% 
Page 42 of 45Respiratory Care
For Peer Review
subjects 
45.4±12.9yrs 
8M:6F  
(ES=0.34) 
G3 
N: Pre 2.5±2.1; Post 2.3±1.8 (ES=-0.1) 
F: Pre 732.6±172.2Hz; Post 701.6±170.1Hz (ES=-0.18)  
WH% monophonic: Pre 37.1±28.7%; Post 48.2±31.6% 
(ES=0.37) 
WH% polyphonic: Pre 15.2±18.9%; Post 10.4±10.9% 
(ES=-0.29) 
 
Beck et al. 
(2007) 
Experimental G1: 12 
children with 
infant viral 
bronchiolitis  
4.9±0.8mont
hs 
4M:8F 
G2: 15 
children with 
infant viral 
bronchiolitis 
4±1.35month
s 
4M:11F 
 
 
G1: Nebulized 
epinephrine 
(1mg diluted with 
2ml of 0.9% saline) 
G2: Nebulized 
albuterol (2.5mg 
diluted with 2.5ml 
of 0.9% saline) 
 
Respiratory sound recordings: 
-performed 5min prior to (pre), 10min 
and 30min post treatment (post1 and 
post2); 
- spontaneous breathing; 
- 5 complete respiratory cycles; 
- at the right and left axillae and posterior 
bases of the lungs. 
Phonopneumogra
phy piezoelectric 
contact sensors 
connected to an 
automatic WH 
detection device 
WHs detection:  
FFT based algorithm 
CRs detection: 
CR counter 
algorithm (to verify 
accuracy, segments 
underwent manual 
auditory analysis) 
WH% 
CR nBC 
G1 
WH%: Pre 9.1±3.4%; Post1 5.47±3.26% (ES=-1.09); 
Post2 7.1±3.63% (ES=-0.57) 
CR nBC: Pre 1.88±0.59; Post1 2.48±0.92 (ES=0.74); 
Post2 2.26±0.7 (ES=0.58) 
G2 
WH%:  Pre 5.5±3.08%; Post1 9.11±2.52% (ES=1.27); 
Post2 11.9±4.5% (ES=1.61) 
CR nBC: Pre 1.74±0.42; Post1 1.14±0.23 (ES=-1.65); 
Post2 1.31±0.33 (ES=-1.12) 
 
Marques et Quasi- 23 subjects Single physical Respiratory sounds recordings:  Electronic CRs detection: CRs: nBC: Pre 4.14±2.31; Post 4.18±2.25 (ES=0.02) 
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al. 
(2012) 
Experimental with 
bronchiectasi
s 
25-73yrs 
9M:14F  
therapy treatment 
with ACBT 
 
-before and after the treatment; 
- spontaneous breathing; 
- 3 recordings of 25s over each chest 
location 
- following the CORSA guidelines for 
short-term acquisition. 
 
stethoscope 
connected to a 
laptop 
 
Vannuccini et al. 
algorithm  
BC detection: 
analogous method 
to that by Que et al. 
plus manual 
adjustment of the 
detection 
thresholds 
nBC  
2CD  
 
2CD: Pre 11.8±1.5ms; Post 11.9±1.54ms (ES=0.07) 
Oliveira et 
al. 
(2013) 
Observational 6 subjects 
with LRTI 
33-63yrs 
3M:3F 
Standard medical 
treatment 
(antibiotics) 
 
Respiratory sounds recordings:  
-within 24 hours of hospital presentation 
and after treatment; 
- spontaneous breathing; 
-3 recordings of 25s over each chest 
location  
-following the CORSA guidelines for short-
term acquisition. 
 
Electronic 
stethoscope 
connected to a 
laptop 
WHs detection: 
Taplidou and 
Hadjileontiadis 
algorithm based on 
Short-time FFT 
WHs: 
N 
F 
Duration 
 
N: Pre 6±0.9; Post 14.8±2.3; p=0.03 (ES=4.38) 
F: Pre 365±37Hz; Post 363±29.1Hz (ES=-0.06)  
Duration: Pre 0.21±0s; Post 0.22±0s (ES=0.11) 
 
Dinis et al. 
(2013) 
Experimental CG: 11 
subjects with 
LTRI 
52.9±18.3yrs 
4M:7F 
EG: 9 subjects 
with LTRI 
49.9±23.2yrs 
CG: Standard 
medical treatment 
(antibiotics) 
EG: Standard 
medical treatment + 
Respiratory physical 
therapy (3*week; 
ACBT, breathing 
Respiratory sounds  recordings: 
- within 24 hours of hospital presentation 
and after treatment; 
- spontaneous breathing; 
-3 recordings of 20s; 
-following the CORSA guidelines for short-
term acquisition. 
 
Modified 
analogue 
stethoscopes 
connected to a 
laptop 
 
 
WHs detection: 
Taplidou and 
Hadjileontiadis 
algorithm based on 
Short-time FFT 
BC detection: 
Huq and Moussavi 
automatic 
WHs: 
WH%  
F 
 
CG 
Inspiration 
WH%: Pre 11.1±14.8%; Post 2.2±6.2%; p<0.001 (ES=-
0.69) 
F: Pre 241.3±60.1Hz; Post 415.5±201.1Hz; p=0.195 
(ES=0.97) 
Expiration 
WH%: Pre 11.3±13.2%; Post 4.1±7.7%; p<0.001 (ES=-
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6M:3F 
 
retraining; incentive 
spirometry; thoracic 
mobility, expansion 
and flexibility 
exercises; aerobic 
training) 
respiratory phase 
detector  
using tracheal 
sounds 
0.62)  
F: Pre 221.2±85.6Hz; Post 396.8±208.1; p=0.243 
(ES=0.97) 
EG 
Inspiration 
WH%: Pre 9.2±14.1%; Post 0.4±1.9%; p<0.001 (ES=-
0.66) 
F: Pre 360.3±221.1Hz; Post 140.2±153.1Hz; p=0.555 
(ES=0.73) 
Expiration 
WH%: Pre 10.5±15.3%; Post 1.9±5.4%; p<0.001 (ES=-
0.64) 
F: Pre 423.2±168.6Hz; Post 432.8±269.1Hz; p=0.915 
(ES=0.04) 
Post CG vs Post EG 
Inspiration 
WH%: 2.2±6.2%; 0.4±1.9%; p=0.019 (ES=0.37) 
Expiration 
WH%: 4.1±7.7%; 1.9±5.4%; p=0.061 (ES=0.33) 
Data are presented as mean±standard deviation 
2CD - two cycle duration; ACBT – active cycle of breathing techniques; BC – breathing cycle; BPT – bronchial provocation test; CG – control group; CORSA - computerized respiratory sound analysis; CR – crackle; EG – experimental group; 
ES – effect size; FFT – fast fourier transformation analysis; F- frequency; Fu - upper frequency at - 20-dB level; FVC- forced vital capacity; IDW - initial deflection width ; Ie - effective intensity; N – number; nBC – number per breathing 
cycle; NWI - nocturnal wheeze index; PF – peak frequency; Se – sensitivity; Sp – specificity; TEW - time-expanded waveform; WH - wheeze; WH% - wheeze occupation rate. 
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